Lipoprotein lipase (LPL) is a key enzyme in the metabolism of triglyceride- rich and high density lipoproteins. Defective functional enzyme is the diagnostic feature of a rare autosomal recessive syndrome, familial LPL deficiency. We have already identified several mutations of the gene in LPL deficient subjects and shown that the heterozygous state for LPL deficiency (LPLn) accounted for familial hypertriglyceridemia (HTG) in a large pedigree. We intend to pursue a systematic genetic and biochemical investigation of LPL in classical deficiency states as well as in a variety of clinical contexts where the pathophysiological significance of HTG is not understood, including coronary heart disease, essential hypertension, diabetes, pregnancy-induced hypertension or diabetes, and acute pancreatitis, recruiting subjects through multiple sources in both Salt Lake City and San Francisco. To achieve these scientific objectives, we propose to: (1) identify mutations of the LPL gene in familial LPL deficiency patients by sequencing LPL exons and intron-exon boundaries; (2) search for mutations of LPL in a large series of HTG subjects in various clinical contexts, screening for known mutations by dot-blot hybridization and for unidentified mutations by direct detection of nucleotide variants (single strand conformation polymorphism or chemical mismatch detection) and DNA sequencing; (3) confirm the functional significance of these mutations by in vitro mutagenesis and expression in mammalian cells; (4) identify the functional domain affected by each mutation by testing catalytic activity with particulate and soluble substrates, affinity for lipid, apolipoprotein C-II and heparin, and self-association to a dimer; (5) perform in vitro expression at residues where substitutions have been identified to investigate structure-function relationships of the domains involved.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL045753-05
Application #
2222469
Study Section
Metabolism Study Section (MET)
Project Start
1994-01-01
Project End
1995-12-31
Budget Start
1995-01-01
Budget End
1995-12-31
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Utah
Department
Genetics
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Pullinger, C R; Love, J A; Liu, W et al. (1996) The apolipoprotein B Q3405E polymorphism has no effect on its low-density-lipoprotein receptor binding affinity. Hum Genet 98:678-80
Pullinger, C R; Hennessy, L K; Chatterton, J E et al. (1995) Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest 95:1225-34
Zysow, B R; Pullinger, C R; Hennessy, L K et al. (1994) The apolipoprotein C-II variant apoC-IILys19-->Thr is not associated with dyslipidemia in an affected kindred. Clin Genet 45:292-7
Wilson, D E; Kwong, L K; Elbein, S C et al. (1994) Genetic predisposition to hyperlipidaemia in diabetes: the end of the beginning? J Intern Med Suppl 736:53-61
Wilson, D E; Hata, A; Kwong, L K et al. (1993) Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes. J Clin Invest 92:203-11
Pullinger, C R; Zysow, B R; Hennessy, L K et al. (1993) Molecular cloning and characteristics of a new apolipoprotein C-II mutant identified in three unrelated individuals with hypercholesterolemia and hypertriglyceridemia. Hum Mol Genet 2:69-74
Hata, A; Ridinger, D N; Sutherland, S et al. (1993) Binding of lipoprotein lipase to heparin. Identification of five critical residues in two distinct segments of the amino-terminal domain. J Biol Chem 268:8447-57
Hata, A; Ridinger, D N; Sutherland, S D et al. (1992) Missense mutations in exon 5 of the human lipoprotein lipase gene. Inactivation correlates with loss of dimerization. J Biol Chem 267:20132-9